The collaboration leverages Basecamp Research’s EDEN models, which were trained on BaseData—a massive biological dataset containing over 10 billion genes sourced from diverse global environments, including deep-sea sediment and polar ice. In laboratory trials conducted alongside the University of Pennsylvania’s Machine Biology Group, 97% of peptides designed by EDEN proved active against WHO-designated priority pathogens. César de la Fuente, who led the research, noted that the model produced the candidate EDEN-7 without iterative engineering, achieving efficacy comparable to last-line antibiotics in mice infected with multidrug-resistant Acinetobacter baumannii.

Beyond antibiotic discovery, the integration accelerates vaccine development by identifying proteins likely to trigger protective immune responses. This process replaces months of empirical laboratory work with a streamlined workflow accessible through Claude. Anthropic’s Jonah Cool emphasized that providing researchers with these tools is essential for tackling urgent public health threats. To ensure the project's long-term growth, Basecamp Research is expanding its data collection through the Trillion Gene Atlas, a multi-partner initiative involving NVIDIA, PacBio, and Ultima Genomics. Each data point remains traceable to its origin, with benefit-sharing agreements ensuring that local communities receive a portion of the value generated by the biological insights discovered in their regions.